Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Visseaux

Showing results (21-30 of 131) with videos related to

Pageof 14
Sort By:
Retrovirology|January 14, 2015
HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cellsLise Chauveau, Isabel Puigdomenech, Diana Ayinde, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 20, 2017
Diagnostic performances of the Xpert<sup>®</sup> Flu PCR test and the OSOM<sup>®</sup> immunochromatographic rapid test for influenza A and B virus among adult patients in the Emergency DepartmentStephanie Antoniol, Nadhira Fidouh, Aiham Ghazali, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 29, 2020
The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?Eric Farfour, Philippe Lesprit, Benoit Visseaux, et al.
The Journal of Antimicrobial Chemotherapy|November 16, 2012
Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trialCharlotte Charpentier, Véronique Joly, Lucile Larrouy, et al.
Journal of Virological Methods|February 12, 2021
Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirementsBenoit Visseaux, Gilles Collin, Nadhira Houhou-Fidouh, et al.
AIDS (London, England)|September 29, 2012
Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patientsLucile Larrouy, Alexandre Vivot, Charlotte Charpentier, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 10, 2021
High-sensitivity SARS-CoV-2 group testing by digital PCR among symptomatic patients in hospital settingsAlexandra Martin, Alexandre Storto, Quentin Le Hingrat, et al.
Plos One|August 7, 2015
Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical IsolatesBenoit Visseaux, Charlotte Charpentier, Gilles Collin, et al.
The Journal of Antimicrobial Chemotherapy|October 28, 2017
No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavirMarine Perrier, Benoit Visseaux, Roland Landman, et al.
AIDS (London, England)|May 19, 2015
High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patientsMélanie Bertine, Charlotte Charpentier, Benoit Visseaux, et al.
Pageof 14

Showing results (21-30 of 131) with videos related to

Sort By:
Pageof 14
Retrovirology|January 14, 2015
HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cellsLise Chauveau, Isabel Puigdomenech, Diana Ayinde, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 20, 2017
Diagnostic performances of the Xpert<sup>®</sup> Flu PCR test and the OSOM<sup>®</sup> immunochromatographic rapid test for influenza A and B virus among adult patients in the Emergency DepartmentStephanie Antoniol, Nadhira Fidouh, Aiham Ghazali, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 29, 2020
The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?Eric Farfour, Philippe Lesprit, Benoit Visseaux, et al.
The Journal of Antimicrobial Chemotherapy|November 16, 2012
Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trialCharlotte Charpentier, Véronique Joly, Lucile Larrouy, et al.
Journal of Virological Methods|February 12, 2021
Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirementsBenoit Visseaux, Gilles Collin, Nadhira Houhou-Fidouh, et al.
AIDS (London, England)|September 29, 2012
Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patientsLucile Larrouy, Alexandre Vivot, Charlotte Charpentier, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 10, 2021
High-sensitivity SARS-CoV-2 group testing by digital PCR among symptomatic patients in hospital settingsAlexandra Martin, Alexandre Storto, Quentin Le Hingrat, et al.
Plos One|August 7, 2015
Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical IsolatesBenoit Visseaux, Charlotte Charpentier, Gilles Collin, et al.
The Journal of Antimicrobial Chemotherapy|October 28, 2017
No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavirMarine Perrier, Benoit Visseaux, Roland Landman, et al.
AIDS (London, England)|May 19, 2015
High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patientsMélanie Bertine, Charlotte Charpentier, Benoit Visseaux, et al.
Pageof 14